Summary: Methods
Whether this increased risk is from their conventional or high-dose therapy (or both) is unknown. Standard pre-transplant cytogenetic screening of bone marrow and/or blood is recommended to detect preleukemia cells. 6 Whether this Cytogenetics approach is effective, however, is unknown.
We report a patient who developed secondary AML 6 years following completion of chemotherapy and radiation Chromosome studies were performed on fresh bone marrow for HD. A 20q− marker chromosome was discovered preand cells harvested from short-term cultures. 8 The cells were transplant in bone marrow but only after analysis of cells treated with colcemid and hypotonic solution (0.075 m KCl) cultured with hematopoietic growth factors (HGF).
followed by a methanol/acetic acid (3:1) fixation. The chromosome preparations were made by air-dry technique and stained with trypsin-Giemsa banding procedure. A mini- Fluorescent in situ hybridization studies (FISH) to the chest followed by 12 cycles of nitrogen mustard, vincristine, prednisone, procarbazine (MOPP) and doxorubicin, bleomycin, vinblastine, and DTIC (ABVD). This was Preparations of metaphase spreads and FISH were carried out on two specimens to confirm the 20q− clone as follows:
followed by 40 Gy to the chest. A complete remission was achieved and an autologous bone marrow was harvested in freshly thawed cryopreserved bone marrow cells obtained from a back-up bone marrow harvest in January 1995 were 1989. The pre-harvest bone marrow biopsy showed a 40-50% cellular marrow with complete normoblastic trilineage hybridized with a PLC1 (Phospholipase C1) probe which maps to 20q12-13.1.
9 A second specimen obtained from maturation. There was no evidence of MDS or AML. Cytogenetics were not performed. In 1994, a bone marrow aspir-9 day cultures of bone marrow aspirated 123 days after autologous bone marrow transplant was hybridized with a ate and biopsy showed a normocellular marrow with megaloblastic erythropoiesis and 22% myeloblasts consistent chromosome 20 paint probe (coatasome; Oncor, Gaithersburg, MD, USA). A specimen with two normal chromowith refractory anemia with excessive blasts in transformation (RAEBIT). Cytogenetic studies showed an interstitial somes was used as a control. (Table 1 ). This was confirmed by FISH analysis (Figure 1 ).
Discussion
Our patient, received extensive chemotherapy and radiation before bone marrow cells were collected. Cytogenetic studies done 6 years later after she had developed myelodysplastic syndrome showed 20q−. The same abnormality was found in the previously collected and cryopreserved bone The most common cytogenetic abnormalities in second- plant therapy.
